BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:04 PM
 | 
Dec 14, 2012
 |  BC Extra  |  Company News

FDA to review Actelion's macitentan for PAH

Actelion Ltd. (SIX:ATLN) said FDA accepted for review an NDA for Opsumit macitentan to treat pulmonary arterial hypertension....

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >